| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_325e8f74339359cd24e45eb790ace68f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-186 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6857
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate |
1993-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dea6ce2a04406928a5fa228f253edd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bf85b916892e800537367b69265c909
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af41c85431737235d29011d89d7597b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60b6242912365c599434489e0311bf43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5c51a8713dc8763a0b5b0e1b1cb6405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee3f05c19feaaadf3792861c63bd8e46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68a3d73d7f4d090ce0d6f36226b7b07b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e472f3e01cd664813359b271cb4641bd |
| publicationDate |
1994-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0586065-A2 |
| titleOfInvention |
Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping using the same |
| abstract |
The present invention relates to an NS4-related antigenic peptide capable of reacting specifically with antibodies directed against Group I of hepatitis C virus (HCV); to an NS4-related antigenic peptide capable of reacting specifically with antibodies directed against Group II of HCV; to a kit for identifying HCV Groups I or II which comprises said peptides in separate sections; and to methods for grouping HCV. The peptides of the present invention can be used to detect HCV Groups I or II specifically as well as the detection of patients having the mixed infection, by which HCV Group II-infected patients can receive early interferon treatment effectively . The peptides are also useful for diagnosis of HCV infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7070790-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5582968-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6416944-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6416946-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5639594-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9605315-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9605315-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5882852-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5871904-A |
| priorityDate |
1992-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |